Novo breathes life into Alzheimer's speculations after executive hunt

As the market awaits clarification on whether Novo Nordisk will move into the market for Alzheimer's treatments, the pharmaceutical firm embarks on a hunt for an executive position with this disease as one of its focus areas.

Photo: Novo Nordisk / PR

Novo Nordisk now breathes life into the question of whether the Danish pharmaceutical firm is serious about officially starting the hunt for the gigantic market for pharmaceutical drugs against the dreaded brain disease Alzheimer's.

In a job posting appearing on, for example, LinkedIn, Novo Nordisk is actively searching for a new Vice President.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs